TY - JOUR
T1 - Evaluating depression with multimodal wristband-type wearable device
T2 - screening and assessing patient severity utilizing machine-learning
AU - Tazawa, Yuuki
AU - Liang, Kuo ching
AU - Yoshimura, Michitaka
AU - Kitazawa, Momoko
AU - Kaise, Yuriko
AU - Takamiya, Akihiro
AU - Kishi, Aiko
AU - Horigome, Toshiro
AU - Mitsukura, Yasue
AU - Mimura, Masaru
AU - Kishimoto, Taishiro
N1 - Funding Information:
Masaro Mimura has received grants and/or speaker’s honoraria from Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Janssen Pharmaceutical, Mochida Pharmaceutical, MSD, Nippon Chemipher, Novartis Pharma, Ono Pharma, Otsuka Pharmaceutical, Pfizer, Takeda Pharma, Tsumura, and Yoshitomi Pharma within the past three years. Taishiro Kishimoto has received consultant fees from Otsuka, Pfizer, and Dainippon Sumitomo, and speaker’s honoraria from Banyu, Eli Lilly, Dainippon Sumitomo, Janssen, Novartis, Otsuka, and Pfizer. This research was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP18he1102004 .
Funding Information:
Masaro Mimura has received grants and/or speaker's honoraria from Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Janssen Pharmaceutical, Mochida Pharmaceutical, MSD, Nippon Chemipher, Novartis Pharma, Ono Pharma, Otsuka Pharmaceutical, Pfizer, Takeda Pharma, Tsumura, and Yoshitomi Pharma within the past three years. Taishiro Kishimoto has received consultant fees from Otsuka, Pfizer, and Dainippon Sumitomo, and speaker's honoraria from Banyu, Eli Lilly, Dainippon Sumitomo, Janssen, Novartis, Otsuka, and Pfizer. This research was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP18he1102004.
Publisher Copyright:
© 2020
PY - 2020/2
Y1 - 2020/2
N2 - Objective: We aimed to develop a machine learning algorithm to screen for depression and assess severity based on data from wearable devices. Methods: We used a wearable device that calculates steps, energy expenditure, body movement, sleep time, heart rate, skin temperature, and ultraviolet light exposure. Depressed patients and healthy volunteers wore the device continuously for the study period. The modalities were compared hourly between patients and healthy volunteers. XGBoost was used to build machine learning models and 10-fold cross-validation was applied for the validation. Results: Forty-five depressed patients and 41 healthy controls participated, creating a combined 5,250 days' worth of data. Heart rate, steps, and sleep were significantly different between patients and healthy volunteers in some comparisons. Similar differences were also observed longitudinally when patients' symptoms improved. Based on seven days' data, the model identified symptomatic patients with 0.76 accuracy and predicted Hamilton Depression Rating Scale-17 scores with a 0.61 correlation coefficient. Skin temperature, sleep time-related features, and the correlation of those modalities were the most significant features in machine learning. Limitations: The small number of subjects who participated in this study may have weakened the statistical significance of the study. There are differences in the demographic data among groups although we performed a correction for multiple comparisons. Validation in independent datasets was not performed, although 10-fold cross validation with the internal data was conducted. Conclusion: The results indicated that utilizing wearable devices and machine learning may be useful in identifying depression as well as assessing severity.
AB - Objective: We aimed to develop a machine learning algorithm to screen for depression and assess severity based on data from wearable devices. Methods: We used a wearable device that calculates steps, energy expenditure, body movement, sleep time, heart rate, skin temperature, and ultraviolet light exposure. Depressed patients and healthy volunteers wore the device continuously for the study period. The modalities were compared hourly between patients and healthy volunteers. XGBoost was used to build machine learning models and 10-fold cross-validation was applied for the validation. Results: Forty-five depressed patients and 41 healthy controls participated, creating a combined 5,250 days' worth of data. Heart rate, steps, and sleep were significantly different between patients and healthy volunteers in some comparisons. Similar differences were also observed longitudinally when patients' symptoms improved. Based on seven days' data, the model identified symptomatic patients with 0.76 accuracy and predicted Hamilton Depression Rating Scale-17 scores with a 0.61 correlation coefficient. Skin temperature, sleep time-related features, and the correlation of those modalities were the most significant features in machine learning. Limitations: The small number of subjects who participated in this study may have weakened the statistical significance of the study. There are differences in the demographic data among groups although we performed a correction for multiple comparisons. Validation in independent datasets was not performed, although 10-fold cross validation with the internal data was conducted. Conclusion: The results indicated that utilizing wearable devices and machine learning may be useful in identifying depression as well as assessing severity.
KW - Biological psychiatry
KW - Biomarkers
KW - Body temp
KW - Clinical research
KW - Depression
KW - Diagnostics
KW - Health informatics
KW - Health technology
KW - Heart rate
KW - Machine learning
KW - Psychiatry
KW - Sleep
KW - Wearable electronic devices
UR - http://www.scopus.com/inward/record.url?scp=85078715050&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078715050&partnerID=8YFLogxK
U2 - 10.1016/j.heliyon.2020.e03274
DO - 10.1016/j.heliyon.2020.e03274
M3 - Article
AN - SCOPUS:85078715050
SN - 2405-8440
VL - 6
JO - Heliyon
JF - Heliyon
IS - 2
M1 - e03274
ER -